Videos
AEROBIKA® OPEP device
AEROBIKA® OPEP device
Please follow these simple instructions when using the AEROBIKA® OPEP device. This video contains abbreviated user instructions. Please read the full product insert before using the device for the first time. Learn more: https://www.monaghanmed.com/product/aerobika/
The AEROBIKA® OPEP device is a cost-effective beneficial therapeutic tool to add to your COPD and Chronic Bronchitis protocols. Watch the video to learn more.
A simple, cost effective solution for lung expansion and airway clearance, Tandem Therapy combines the advantages of both the AEROBIKA® and VersaPAP® devices. Tandem Therapy creates a synergy between the devices to enable patients to take deeper breaths and longer exhalations, optimizing lung expansion and airway clearance simultaneously. Watch the video to learn more.
This video shows you how to combine the AEROBIKA® OPEP device with your nebulizer treatment for effective aerosol delivery. For more information visit: www.aerobika.us
AEROCHAMBER PLUS®️ FLOW-VU®️ aVHC
AEROCHAMBER PLUS®️ FLOW-VU®️ aVHC
Metered Dose Inhalers should always be used together with an AEROCHAMBER® device. Inhaler devices have experienced continuous innovation over the years. However, inhaler technique has not improved over time. This short video describes why you should always use a chamber with your inhaler. Learn more: https://www.monaghanmed.com/product/aerochamber-plus-flow-vu-avhc/
The AEROBIKA® OPEP device is a cost-effective beneficial therapeutic tool to add to your COPD and Chronic Bronchitis protocols. Watch the video to learn more.
AEROECLIPSE® Nebulizer
AEROECLIPSE® Nebulizer
This study compared medication delivery between two different nebulizer compressor combinations. Cystic Fibrosis. Learn more about AEROECLIPSE® XL R BAN™ Nebulizer with OMBRA® Compressor. https://bit.ly/3BJE1pL
Stop wasting expensive medication by using a nebulizer that puts more aerosol into the environment than into the lungs where it can treat symptoms. Visit our site to learn more about the AEROECLIPSE® II BAN™ Nebulizer. https://bit.ly/3QmLGyH
This study investigated the impact of various breathing patterns and nebulizer selection on fugitive aerosol emissions. The AEROECLIPSE® II BAN™ Nebulizer with Breath Actuated technology substantially reduced fugitive emissions for all breathing patterns compared to other styles of nebulizers. Learn more here: https://bit.ly/3QmLGyH
Nebulizing medications is a common therapy for the treatment of respiratory conditions, but harmful fugitive emissions from the nebulizer may increase the risk of exposure to others in the room. Lean more about Monaghan Medical products here: https://www.monaghanmed.com/product/aeroeclipse-ii-nebulizer/
Harborview Medical Center Study -AeroEclipse II® BAN – Reduction of 30 day re-admission rate and COPD LOS
Under-dosing of inhaled medication delivered by continuous nebulizers is possible as the result of changes to the Inspiratory/Expiratory (I/E) ratio.
Chesapeake AeroEclipse II® BAN Efficiency Study
The AEROECLIPSE® Nebulizer significantly minimizes aerosol emissions compared to other nebulizers available – creating a safer work environment and reducing the risks associated with breathing in secondhand aerosols.
AEROVERSE™ system
AEROVERSE™ SYSTEM
Three Monaghan Medical products, seven different therapy options. Say “hello” to the AEROVERSE™ system of care. Contact your Monaghan Medical Sales Territory Manger for more information.
Educational Series
Educational Series
Curious if adding a valved holding chamber to Metered Dose Inhaler (MDI) therapy can really improve the amount of medication that can get into the lungs? Watch a quick synopsis of a recent study published using Functional Respiratory Imaging (FRI) to understand what happens to medication delivery in the lungs with the use of a valved holding chamber compared to using an MDI alone. American Journal of Respiratory and Critical Care Medicine 2020;201:A5689 View Study Poster
Medications to manage care of cystic fibrosis patients are often delivered via nebulizer. However, there are sometimes questions around the dose delivered to the patient when changing between a continuous and a breath actuated delivery device. In this video we review the delivery performance versus a Breath Enhanced Nebulizer (BEN) commonly used with such medications.
We are pleased to share with you Drug Delivery Performance and Potential for Fugitive Emission From Commercially Available Nebulizer Systems. Delivery of inhaled medications by nebulizer for the treatment of respiratory disease is widespread. Important factors to consider in a delivery system are the amount and consistency of drug delivered to the lungs, as well as the amount of material that is admitted to the local environment (Fugitive Emissions).
We are pleased to share with you Drug Delivery Performance and Potential for Fugitive Emission From Commercially Available Nebulizer Systems. Delivery of inhaled medications by nebulizer for the treatment of respiratory disease is widespread. Important factors to consider in a delivery system are the amount and consistency of drug delivered to the lungs, as well as the amount of material that is admitted to the local environment (Fugitive Emissions).
We are pleased to share with you Drug Delivery Performance and Potential for Fugitive Emission From Commercially Available Nebulizer Systems. Delivery of inhaled medications by nebulizer for the treatment of respiratory disease is widespread. Important factors to consider in a delivery system are the amount and consistency of drug delivered to the lungs, as well as the amount of material that is admitted to the local environment (Fugitive Emissions).
Oscillating Positive Expiratory Pressure (OPEP) Devices and Airway Clearance Therapy in the Covid-19 Patient Care Pathway: A Review of Where There May be Clinical Value
Metered Dose Inhaler (MDI) with Valved Holding Chamber (VHC) vs Dry Powder Inhalers (DPIs): Using Functional Respiratory Imaging (FRI) to Assess Modelled Lung Deposition in an Asthmatic patient.
Dose Assurance with Nebulizer Therapy – A Laboratory Investigation into the Medication Delivery Performance of a Range of Different Nebulizers at Different Inspiratory/Expiratory Ratios
Testimonials
Testimonials
See why our customers choose the AEROBIKA® OPEP device for their patients with CF.
The AEROCLIPSE® BAN is truly a lifesaving device. See what Greg Morgan has to say about this lifesaving product.
Julie Smith, Manager of Respiratory Care at UnityPoint Health in St. Luke’s, Iowa swears by the AEROBIKA® OPEP device to treat her patients. Watch her explain why she puts her trust in Monaghan.
The Director of Respiratory Care at Lakewood Ranch Medical Center, Florida has been using Monaghan products in his patients’ care plan for years. See what he has to say about why he agrees that with Monaghan, quality matters.
Monaghan Medical’s products go through extensive testing and validation. See what professionals in the field have to say about the importance of using tested and quality products for their patients.
Why we recommend using AEROBIKA® OPEP device? See what Jodi Jaeger, Manager Respiratory Car Services at Wheaton Franciscan – St. Joseph Campus, Milwaukee has to say about this device. For more information visit: https://www.aerobika.us/
Cheryl Hoerr, Director Respiratory and Sleep Services at Phelps County Regional Medical Center, Missouri, tells us why the AEROBIKA® OPEP device is easy to use. For more information visit: https://www.aerobika.us/
Why does device quality matter? See what our customers have to say about AEROECLIPSE® Nebulizer.
